Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
Joao Pedro FerreiraFaiez ZannadJaved ButlerGerasimos FilipattosIvana RitterElke SchülerBettina J KrausStuart J PocockStefan D AnkerMilton PackerPublished in: European heart journal (2022)
Empagliflozin reduced the incidence of hyperkalaemia without significant increase in hypokalaemia.